Ethical considerations for pharmacogenomic testing in pediatric clinical care and research

In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes

(2010) U. Nowak-Gottl et al.   BLOOD

Understanding the Relative Roles of Pharmacogenetics and Ontogeny in Pediatric Drug Development and Regulatory Science

(2010) J. Steven Leeder et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Views of Discrimination among Individuals Confronting Genetic Disease

(2010) Robert Klitzman   Journal of Genetic Counseling

How Will GINA Influence Participation in Pharmacogenomics Research and Clinical Testing?

(2009) L G Dressler et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis

(2009) Shuang Yang et al.   PEDIATRIC BLOOD & CANCER

Pharmacogenetic testing: not as simple as it seems

(2008) Susanne B Haga et al.   GENETICS IN MEDICINE

The Genetics Revolution and Primary Care Pediatrics

(2008) Tina L. Cheng et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Delivery of Genomic Medicine for Common Chronic Adult Diseases

(2008) Maren T. Scheuner et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Direct-to-consumer genome scanning services. Also for children?

(2008) Pascal Borry et al.   NATURE REVIEWS GENETICS

Pharmacogenetics of Intestinal Absorption

(2008) Tsutomu Nakamura et al.   Current Drug Delivery

The FDA announces new drug labeling for pharmacogenetic testing: Is personalized medicine becoming a reality?

(2007) Georgirene D. Vladutiu   MOLECULAR GENETICS AND METABOLISM